Alcon Laboratories, Inc.
6201 South Freeway
115 articles with Alcon Laboratories, Inc.
Alcon Laboratories, Inc.'s Tender Offer Endorsed by WaveLight's Executive Committee and Supervisory Board
Ascent Healthcare Solutions Receives 510(k) Clearance on Alcon Laboratories, Inc. MACKOOL Phaco Tips
Alcon Laboratories, Inc. Shareholders Approve Dividend and Elect a New Member to the Board
Alcon, Inc. Relesase: Leading Scientists Honored for Outstanding Ophthalmic Research
Alcon Laboratories, Inc.'s AcrySof(R) ReSTOR(R) Apodized Diffractive Aspheric Intraocular Lens Approved By FDA
Alcon Laboratories, Inc. Announces Voluntary Recall Of Systane(R) Free LIQUID GEL Lubricant Eye Drops In The United States, Including Puerto Rico
The Day In Review: Merck & Co., Inc. Gets European Approval Of Gardasil
NovaCal Pharmaceuticals, Inc. Licenses Novel Anti-Infective Compounds For Eye, Ear And Sinus Infections To Alcon Laboratories, Inc.
Alcon, Inc. Increases Share Repurchase Program
Alcon Laboratories, Inc.'s VEGAMOX(TM) Ophthalmic Solution Approved In Japan For Eye Infections
The Day In Review: Biotech 4.5% Higher In 3 Days
Alcon Laboratories, Inc. And Advanced Medical Optics, Inc. Settle All Pending Patent Litigation
Advanced Medical Optics, Inc. Announces Settlement With Alcon Laboratories, Inc. Of Patent Infringement Suits
Origenis Extends Research Alliance With Alcon Research, Ltd. To Develop Novel Ophthalmic Compounds
Alcon Laboratories, Inc. Announces Second Quarter 2006 Financial Release And Conference Call Dates
Alcon Laboratories, Inc. Release: AcrySof(R) IQ IOL Designated As A New Technology Intraocular Lens
Alcon Laboratories, Inc. Withdraws European Application For RETAANE(R) Suspension
Frost & Sullivan Presents Alcon Laboratories, Inc. With Market Leadership Award
Alcon Laboratories, Inc. Announces Fourth Quarter 2005 Financial Release And Conference Call Dates
Kalypsys, Inc. Announces Small Molecule Research Collaboration With Alcon, Inc.